Levofloxacin

Levofloxacin hydrochloride. Chemical name: (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-[1,4]-benzoxazine-6-carboxylic acid hydrochloride monohydrate.

Applicable to infections caused by sensitive bacteria: 1. Urinary and reproductive system infections, including simple and complicated urinary tract infections, bacterial prostatitis, and gonorrheal Neisseria urethritis; 2. Respiratory tract infections, including acute attacks of bronchial infections and lung infections caused by sensitive Gram-negative bacilli; 3. Gastrointestinal infections, caused by Shigella, Salmonella, enterotoxigenic Escherichia coli, Aeromonas hydrophila, Vibrio parahaemolyticus, etc.; 4. Typhoid fever; 5. Bone and joint infections; 6. Skin and soft tissue infections; 7. Systemic infections such as sepsis; 8. Chronic bronchitis.

Intravenous drip: 4 vials per day for adults, divided into 2 intravenous drips. For patients with severe infection and those whose pathogens are less sensitive to this product (such as Pseudomonas aeruginosa), the maximum daily dose can be increased to 6 vials, divided into 2 intravenous drips. (Each time, dilute with 5% glucose injection or 0.9% sodium chloride injection and drip intravenously.) The dose can be appropriately increased or decreased according to the type and symptoms of infection.

During medication, digestive symptoms such as nausea, vomiting, abdominal discomfort, diarrhea, loss of appetite, abdominal pain, and bloating may occur; neurological symptoms such as insomnia, dizziness, and headache; rash, itching, erythema, and redness, itching, or phlebitis at the injection site may occur. Transient liver function abnormalities may also occur, such as increased blood transaminase and increased serum total bilirubin. The incidence of the above adverse reactions is between 0.1 and 5%. Occasionally, blood urea nitrogen rises, fatigue, fever, palpitations, abnormal taste, and vascular pain after injection are observed, which are generally tolerated and disappear quickly after the end of the course of treatment.

1. It is not suitable for children and adolescents under 18 years old; 2. It should be used with caution in pregnant and lactating women; 3. It is contraindicated for patients who are allergic to this product and fluoroquinolones.

Precautions for children: Not suitable for children and adolescents under 18 years old. Precautions for pregnancy and lactation: Use with caution in pregnant and lactating women.

Store in a cool place.

Shaoxing Jingxin Pharmaceutical Co., Ltd.

• Founded in:

  2004-12-17

• Address:

  No. 31, Weisan Road, Shangyu Economic and Technological Development Zone, Hangzhou Bay, Zhejiang Province

• Tax NO.:

  91330604769633544R

• Registered Funds:

  150 million yuan

• Website:

  Log in to view

• Email:

  Log in to view